LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read moreThu, 04th Feb 2021 11:27
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read more(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.
Read more(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.
Read more(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:
Read more(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.
Read more(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.
Read more(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.
Read more(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.
Read more(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.
Read more(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.
Read more(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.
Read moreApril 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.
Read more(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.
Read more